ºÝºÝߣshows by User: DrBKAgrawal / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: DrBKAgrawal / Tue, 17 Nov 2020 11:12:50 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: DrBKAgrawal Top 10 pharmaceutical conferences in 2021 /slideshow/top-10-pharmaceutical-conferences-in-2021/239296474 top10pharmaceuticalconferencesin2021-201117111250
The most thrilling international pharma events, from conferences to meetings & workshops, this is the list not to be missed for pharma professionals. Check out our list of Top 10 Pharmaceutical conferences: 1. International Conference on Cell and Gene Therapy 2. BIO-Europe Spring 2021 3. DUPHAT- 2021 : https://duphat.ae/ 4. CPHI India 2021 5. DIA Europe 2021 6. BIO Asia International Conference 2021 7. BIO International Convention 8. CAR TCR EUROPE 2021 9. Pharma Forum 2021 10. 4th Annual Bioprocessing Summit Europe]]>
The most thrilling international pharma events, from conferences to meetings & workshops, this is the list not to be missed for pharma professionals. Check out our list of Top 10 Pharmaceutical conferences: 1. International Conference on Cell and Gene Therapy 2. BIO-Europe Spring 2021 3. DUPHAT- 2021 : https://duphat.ae/ 4. CPHI India 2021 5. DIA Europe 2021 6. BIO Asia International Conference 2021 7. BIO International Convention 8. CAR TCR EUROPE 2021 9. Pharma Forum 2021 10. 4th Annual Bioprocessing Summit Europe]]> Tue, 17 Nov 2020 11:12:50 GMT /slideshow/top-10-pharmaceutical-conferences-in-2021/239296474 DrBKAgrawal@slideshare.net(DrBKAgrawal) Top 10 pharmaceutical conferences in 2021 DrBKAgrawal The most thrilling international pharma events, from conferences to meetings & workshops, this is the list not to be missed for pharma professionals. Check out our list of Top 10 Pharmaceutical conferences: 1. International Conference on Cell and Gene Therapy 2. BIO-Europe Spring 2021 3. DUPHAT- 2021 : https://duphat.ae/ 4. CPHI India 2021 5. DIA Europe 2021 6. BIO Asia International Conference 2021 7. BIO International Convention 8. CAR TCR EUROPE 2021 9. Pharma Forum 2021 10. 4th Annual Bioprocessing Summit Europe <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/top10pharmaceuticalconferencesin2021-201117111250-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The most thrilling international pharma events, from conferences to meetings &amp; workshops, this is the list not to be missed for pharma professionals. Check out our list of Top 10 Pharmaceutical conferences: 1. International Conference on Cell and Gene Therapy 2. BIO-Europe Spring 2021 3. DUPHAT- 2021 : https://duphat.ae/ 4. CPHI India 2021 5. DIA Europe 2021 6. BIO Asia International Conference 2021 7. BIO International Convention 8. CAR TCR EUROPE 2021 9. Pharma Forum 2021 10. 4th Annual Bioprocessing Summit Europe
Top 10 pharmaceutical conferences in 2021 from Dr. B.K. Agrawal
]]> 22 0 https://cdn.slidesharecdn.com/ss_thumbnails/top10pharmaceuticalconferencesin2021-201117111250-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Soft tissue Sarcoma Market /DrBKAgrawal/soft-tissue-sarcoma-market-234175589 softtissueppt-200518054257
DelveInsight’s ‘Soft Tissue Sarcoma Market Insights, Epidemiology, and Market Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Soft Tissue Sarcoma (STS) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. https://www.delveinsight.com/report-store/soft-tissue-sarcoma-market The Soft Tissue Sarcoma market report provides analysis regarding current treatment practices, emerging drugs like AL3818, Fibromun, AL3818, Ripretinib, market share of the individual therapies, historical, current and forecasted Soft Tissue Sarcoma market Size from 2017 to 2030 segmented by seven major markets.]]>
DelveInsight’s ‘Soft Tissue Sarcoma Market Insights, Epidemiology, and Market Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Soft Tissue Sarcoma (STS) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. https://www.delveinsight.com/report-store/soft-tissue-sarcoma-market The Soft Tissue Sarcoma market report provides analysis regarding current treatment practices, emerging drugs like AL3818, Fibromun, AL3818, Ripretinib, market share of the individual therapies, historical, current and forecasted Soft Tissue Sarcoma market Size from 2017 to 2030 segmented by seven major markets.]]> Mon, 18 May 2020 05:42:57 GMT /DrBKAgrawal/soft-tissue-sarcoma-market-234175589 DrBKAgrawal@slideshare.net(DrBKAgrawal) Soft tissue Sarcoma Market DrBKAgrawal DelveInsight’s ‘Soft Tissue Sarcoma Market Insights, Epidemiology, and Market Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Soft Tissue Sarcoma (STS) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. https://www.delveinsight.com/report-store/soft-tissue-sarcoma-market The Soft Tissue Sarcoma market report provides analysis regarding current treatment practices, emerging drugs like AL3818, Fibromun, AL3818, Ripretinib, market share of the individual therapies, historical, current and forecasted Soft Tissue Sarcoma market Size from 2017 to 2030 segmented by seven major markets. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/softtissueppt-200518054257-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> DelveInsight’s ‘Soft Tissue Sarcoma Market Insights, Epidemiology, and Market Forecast-2030’ report deliver an in-depth understanding of the disease, historical &amp; forecasted epidemiology as well as the market trends of Soft Tissue Sarcoma (STS) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. https://www.delveinsight.com/report-store/soft-tissue-sarcoma-market The Soft Tissue Sarcoma market report provides analysis regarding current treatment practices, emerging drugs like AL3818, Fibromun, AL3818, Ripretinib, market share of the individual therapies, historical, current and forecasted Soft Tissue Sarcoma market Size from 2017 to 2030 segmented by seven major markets.
Soft tissue Sarcoma Market from Dr. B.K. Agrawal
]]> 84 1 https://cdn.slidesharecdn.com/ss_thumbnails/softtissueppt-200518054257-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Non-Small Cell Lung Cancer Pipeline Insight | Non-Small Cell Lung Cancer Pipeline Assessment, Pipeline Drugs /slideshow/nonsmall-cell-lung-cancer-pipeline-insight-nonsmall-cell-lung-cancer-pipeline-assessment-pipeline-drugs/232914130 nsclcpipeline-200430123212
NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.]]>
NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.]]> Thu, 30 Apr 2020 12:32:12 GMT /slideshow/nonsmall-cell-lung-cancer-pipeline-insight-nonsmall-cell-lung-cancer-pipeline-assessment-pipeline-drugs/232914130 DrBKAgrawal@slideshare.net(DrBKAgrawal) Non-Small Cell Lung Cancer Pipeline Insight | Non-Small Cell Lung Cancer Pipeline Assessment, Pipeline Drugs DrBKAgrawal NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nsclcpipeline-200430123212-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.
Non-Small Cell Lung Cancer Pipeline Insight | Non-Small Cell Lung Cancer Pipeline Assessment, Pipeline Drugs from Dr. B.K. Agrawal
]]> 67 0 https://cdn.slidesharecdn.com/ss_thumbnails/nsclcpipeline-200430123212-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030 /slideshow/nonsmall-cell-lung-cancer-market-is-expected-to-increase-with-a-cagr-of-107-for-the-study-period-of-20172030/232913634 nsclcmarket-200430122352
DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio. Key Highlights from report are: As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017. These cases are expected to grow with a significant CAGR in the study period 2017–2030. There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting. The market size of NSCLC in the 7MM is expected to increase during study period. According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.]]>
DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio. Key Highlights from report are: As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017. These cases are expected to grow with a significant CAGR in the study period 2017–2030. There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting. The market size of NSCLC in the 7MM is expected to increase during study period. According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.]]> Thu, 30 Apr 2020 12:23:52 GMT /slideshow/nonsmall-cell-lung-cancer-market-is-expected-to-increase-with-a-cagr-of-107-for-the-study-period-of-20172030/232913634 DrBKAgrawal@slideshare.net(DrBKAgrawal) Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030 DrBKAgrawal DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio. Key Highlights from report are: As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017. These cases are expected to grow with a significant CAGR in the study period 2017–2030. There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting. The market size of NSCLC in the 7MM is expected to increase during study period. According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nsclcmarket-200430122352-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on &quot;Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030&quot; to its portfolio. Key Highlights from report are: As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017. These cases are expected to grow with a significant CAGR in the study period 2017–2030. There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting. The market size of NSCLC in the 7MM is expected to increase during study period. According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030 from Dr. B.K. Agrawal
]]> 81 0 https://cdn.slidesharecdn.com/ss_thumbnails/nsclcmarket-200430122352-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Top 10 international cell therapy conferences /slideshow/top-10-international-cell-therapy-conferences/227578645 top10internationalcelltherapyconferences-200211041528
Top 10 international cell therapy conferences]]>
Top 10 international cell therapy conferences]]> Tue, 11 Feb 2020 04:15:28 GMT /slideshow/top-10-international-cell-therapy-conferences/227578645 DrBKAgrawal@slideshare.net(DrBKAgrawal) Top 10 international cell therapy conferences DrBKAgrawal Top 10 international cell therapy conferences <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/top10internationalcelltherapyconferences-200211041528-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Top 10 international cell therapy conferences
Top 10 international cell therapy conferences from Dr. B.K. Agrawal
]]> 25 0 https://cdn.slidesharecdn.com/ss_thumbnails/top10internationalcelltherapyconferences-200211041528-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Cholangiocarcinoma Market /slideshow/cholangiocarcinoma-market/159100697 ccappt-190730121453
Cholangiocarcinoma is a rare and heterogeneous malignant neoplasm with epithelial cell origin of biliary duct and histologic and biochemical features of cholangiocyte differentiation. The malignant tumor may arise from any portion of the bile duct i.e., from terminal ductules to the ampulla of Vater, and at the peribiliary glands. ]]>
Cholangiocarcinoma is a rare and heterogeneous malignant neoplasm with epithelial cell origin of biliary duct and histologic and biochemical features of cholangiocyte differentiation. The malignant tumor may arise from any portion of the bile duct i.e., from terminal ductules to the ampulla of Vater, and at the peribiliary glands. ]]> Tue, 30 Jul 2019 12:14:53 GMT /slideshow/cholangiocarcinoma-market/159100697 DrBKAgrawal@slideshare.net(DrBKAgrawal) Cholangiocarcinoma Market DrBKAgrawal Cholangiocarcinoma is a rare and heterogeneous malignant neoplasm with epithelial cell origin of biliary duct and histologic and biochemical features of cholangiocyte differentiation. The malignant tumor may arise from any portion of the bile duct i.e., from terminal ductules to the ampulla of Vater, and at the peribiliary glands. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ccappt-190730121453-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Cholangiocarcinoma is a rare and heterogeneous malignant neoplasm with epithelial cell origin of biliary duct and histologic and biochemical features of cholangiocyte differentiation. The malignant tumor may arise from any portion of the bile duct i.e., from terminal ductules to the ampulla of Vater, and at the peribiliary glands.
Cholangiocarcinoma Market from Dr. B.K. Agrawal
]]> 161 4 https://cdn.slidesharecdn.com/ss_thumbnails/ccappt-190730121453-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Charcot Marie Tooth Market /slideshow/charcot-marie-tooth-market-155138870/155138870 charcotmarietooth-converted-190712101642
Charcot Marie tooth disease is one of the hereditary motor and sensory neuropathies, a group of varied inherited disorders of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body. ]]>
Charcot Marie tooth disease is one of the hereditary motor and sensory neuropathies, a group of varied inherited disorders of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body. ]]> Fri, 12 Jul 2019 10:16:42 GMT /slideshow/charcot-marie-tooth-market-155138870/155138870 DrBKAgrawal@slideshare.net(DrBKAgrawal) Charcot Marie Tooth Market DrBKAgrawal Charcot Marie tooth disease is one of the hereditary motor and sensory neuropathies, a group of varied inherited disorders of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/charcotmarietooth-converted-190712101642-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Charcot Marie tooth disease is one of the hereditary motor and sensory neuropathies, a group of varied inherited disorders of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body.
Charcot Marie Tooth Market from Dr. B.K. Agrawal
]]> 28 1 https://cdn.slidesharecdn.com/ss_thumbnails/charcotmarietooth-converted-190712101642-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 ARDS Market | Acute respiratory distress syndrome Market /slideshow/ards-market-acute-respiratory-distress-syndrome-market/154859232 finalpptards-190711052442
Acute Respiratory Distress Syndrome (ARDS) is a life-threatening severe orphan disease in which the air sacs present in alveoli are filled with fluid and lower the amount of oxygen in the blood. Thus, enough oxygen is not supplied to the body. Inflammation may occur throughout the lungs. ]]>
Acute Respiratory Distress Syndrome (ARDS) is a life-threatening severe orphan disease in which the air sacs present in alveoli are filled with fluid and lower the amount of oxygen in the blood. Thus, enough oxygen is not supplied to the body. Inflammation may occur throughout the lungs. ]]> Thu, 11 Jul 2019 05:24:42 GMT /slideshow/ards-market-acute-respiratory-distress-syndrome-market/154859232 DrBKAgrawal@slideshare.net(DrBKAgrawal) ARDS Market | Acute respiratory distress syndrome Market DrBKAgrawal Acute Respiratory Distress Syndrome (ARDS) is a life-threatening severe orphan disease in which the air sacs present in alveoli are filled with fluid and lower the amount of oxygen in the blood. Thus, enough oxygen is not supplied to the body. Inflammation may occur throughout the lungs. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/finalpptards-190711052442-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Acute Respiratory Distress Syndrome (ARDS) is a life-threatening severe orphan disease in which the air sacs present in alveoli are filled with fluid and lower the amount of oxygen in the blood. Thus, enough oxygen is not supplied to the body. Inflammation may occur throughout the lungs.
ARDS Market | Acute respiratory distress syndrome Market from Dr. B.K. Agrawal
]]> 190 3 https://cdn.slidesharecdn.com/ss_thumbnails/finalpptards-190711052442-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Acute Bacterial Skin and Skin-Structure Infection-ABSSSI /slideshow/acute-bacterial-skin-and-skinstructure-infectionabsssi/146244844 absssippt-190517113328
DelveInsight’s ABSSSI market report gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology. For more information on ABSSSI market, click here: ABSSSI Market ]]>
DelveInsight’s ABSSSI market report gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology. For more information on ABSSSI market, click here: ABSSSI Market ]]> Fri, 17 May 2019 11:33:28 GMT /slideshow/acute-bacterial-skin-and-skinstructure-infectionabsssi/146244844 DrBKAgrawal@slideshare.net(DrBKAgrawal) Acute Bacterial Skin and Skin-Structure Infection-ABSSSI DrBKAgrawal DelveInsight’s ABSSSI market report gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology. For more information on ABSSSI market, click here: <a href="https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast">ABSSSI Market</a> <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/absssippt-190517113328-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> DelveInsight’s ABSSSI market report gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology. For more information on ABSSSI market, click here: ABSSSI Market
Acute Bacterial Skin and Skin-Structure Infection-ABSSSI from Dr. B.K. Agrawal
]]> 259 3 https://cdn.slidesharecdn.com/ss_thumbnails/absssippt-190517113328-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 House dust mite allergy /slideshow/house-dust-mite-allergy-139020032/139020032 housedustmiteallergy-190401071117
House Dust Mite Allergy is an allergic reaction to tiny bugs that commonly live in house dust ]]>
House Dust Mite Allergy is an allergic reaction to tiny bugs that commonly live in house dust ]]> Mon, 01 Apr 2019 07:11:17 GMT /slideshow/house-dust-mite-allergy-139020032/139020032 DrBKAgrawal@slideshare.net(DrBKAgrawal) House dust mite allergy DrBKAgrawal House Dust Mite Allergy is an allergic reaction to tiny bugs that commonly live in house dust <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/housedustmiteallergy-190401071117-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> House Dust Mite Allergy is an allergic reaction to tiny bugs that commonly live in house dust
House dust mite allergy from Dr. B.K. Agrawal
]]> 57 4 https://cdn.slidesharecdn.com/ss_thumbnails/housedustmiteallergy-190401071117-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Hepatocellular Carcinoma (HCC) /slideshow/hepatocellular-carcinoma-hcc-124339693/124339693 ppthccvisme-181129070734
Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and, also a leading cause of cancer-related death worldwide. ]]>
Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and, also a leading cause of cancer-related death worldwide. ]]> Thu, 29 Nov 2018 07:07:34 GMT /slideshow/hepatocellular-carcinoma-hcc-124339693/124339693 DrBKAgrawal@slideshare.net(DrBKAgrawal) Hepatocellular Carcinoma (HCC) DrBKAgrawal Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and, also a leading cause of cancer-related death worldwide. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ppthccvisme-181129070734-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and, also a leading cause of cancer-related death worldwide.
Hepatocellular Carcinoma (HCC) from Dr. B.K. Agrawal
]]> 220 3 https://cdn.slidesharecdn.com/ss_thumbnails/ppthccvisme-181129070734-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 ALLERGIC RHINITIS /slideshow/allergic-rhinitis-114938683/114938683 allergicrhinitisppt-180917061610
Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes.]]>
Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes.]]> Mon, 17 Sep 2018 06:16:10 GMT /slideshow/allergic-rhinitis-114938683/114938683 DrBKAgrawal@slideshare.net(DrBKAgrawal) ALLERGIC RHINITIS DrBKAgrawal Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/allergicrhinitisppt-180917061610-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes.
ALLERGIC RHINITIS from Dr. B.K. Agrawal
]]> 62 1 https://cdn.slidesharecdn.com/ss_thumbnails/allergicrhinitisppt-180917061610-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/top10pharmaceuticalconferencesin2021-201117111250-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/top-10-pharmaceutical-conferences-in-2021/239296474 Top 10 pharmaceutical ... https://cdn.slidesharecdn.com/ss_thumbnails/softtissueppt-200518054257-thumbnail.jpg?width=320&height=320&fit=bounds DrBKAgrawal/soft-tissue-sarcoma-market-234175589 Soft tissue Sarcoma Ma... https://cdn.slidesharecdn.com/ss_thumbnails/nsclcpipeline-200430123212-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/nonsmall-cell-lung-cancer-pipeline-insight-nonsmall-cell-lung-cancer-pipeline-assessment-pipeline-drugs/232914130 Non-Small Cell Lung Ca...